SREBF1 and metabolic dysfunction-associated steatotic liver disease: Astaxanthin was also investigated as a preventive of NAFLD through its decrease in SREBP1/2 expression, which inhibits oxidative stress and inflammation, and through activation of PPARα, which significantly promotes fatty acid oxidation and suppresses the production of triglycerides.